Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth rate of around 18% between FY26 and FY31. Growth is expected to be led by Mamaearth, with revenue projected to exceed ₹2,000 crore, while The Derma Co is expected to contribute nearly ₹1,500 crore by FY31.
Largecaps look better as smallcaps price in strong growth: Franklin Templeton’s Arihant Jain
Largecap stocks offer a better risk-reward balance than mid- and small-caps as higher growth expectations are already priced into smaller companies, according to Arihant Jain